Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin in metastatic breast cancer with elevated eIF4E
NCT01056757Phase 2Terminated
- Sponsor
- Jewish General Hospital
- Start
- Dec 2009
- Primary completion
- Nov 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in breast cancer, sponsored by Jewish General Hospital. Started Dec 2009; status: terminated.
02
Drugs
ribavirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01056757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056757.